Best of the Blog is a monthly column highlighting the best of our free online content at www.windhover.com/blog. In October, Windhover's editorial staff posted 25 articles to the site, covering biopharma R&D, business development, regulatory and commercial news. Highlights included our ongoing conference coverage and more analysis of the theoretical biodollar-to-dollar exchange rate. Here are a few of our favorite blog posts and excerpts for stories not covered elsewhere in this month's IN VIVO.
(October 13.) The surprise approval of iloperidone (Fanapt) earned back in May by Vanda Pharmaceuticals Inc. had a lot...